A complex probiotic capable of synergistically metabolizing pectic polysaccharides and application thereof
By co-culturing a compound probiotic strain of *Lactobacillus plantarum* and *Lactobacillus rhamnosus* in a pectin-based carbon source medium, the problem of low efficiency in pectin metabolism by a single strain was solved, achieving efficient metabolism of pectin polysaccharides and short-chain fatty acids, which can be applied in the food and pharmaceutical fields.
Patent Information
- Application Number
- CN202411390913.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-08
- Publication Date
- 2025-11-28
- Estimated Expiration
- 2044-10-08
AI Technical Summary
Currently, probiotics are inefficient at metabolizing pectin polysaccharides, leading to interference with mineral absorption and reduced drug efficacy. Single strains also have limitations in terms of overall probiotic performance.
A compound probiotic strain consisting of Lactiplantibacillus plantarum FMBL L23180 CLL and Lacticaseibacillus rhamnosus FMBL L23121 YWT was co-cultured in a pectin-based carbon source medium to achieve rapid proliferation and efficient metabolism of pectin polysaccharides, producing a large amount of short-chain fatty acids.
Compound probiotics significantly increased biomass and prebiotic index in pectin-based carbon source culture medium, and the yield of short-chain fatty acids at the end of fermentation was significantly higher than that of single culture. It can be used to prepare products such as microcapsules, compound probiotic agents, fermented milk, fruit and vegetable beverages and probiotic milk tablets.